L&G Healthcare Breakthrough UCITS ETF USD Acc ISIN IE00BK5BC677, WKN A2PM51

 
Add to portfolio Watch Compare
 
 
 
 

Current quote and strategy of L&G Healthcare Breakthrough UCITS ETF USD Acc

Quote
EUR 14.12
Last quote
14.01.22
14.12 52 weeks low/high 17.47
52 weeks low/high
 
Investment strategy

The ROBO Global Healthcare Technology and Innovation index tracks the performance of companies that are actively engaged in the healthcare technology value-chain.

 

ROBO Global Healthcare Technology and Innovation (1)

Equity (1185) World (286) Health Care (12)
 

Risk and fees of L&G Healthcare Breakthrough UCITS ETF USD Acc

Risk
EUR 174 m
Fund size
Fund size category

Replication

Physical (Full replication)
Legal structure ETF
Strategy risk Long-only
Fund currency USD

Currency risk

Currency unhedged
Volatility 1 year (in EUR) 21.94% Risk category
Inception/ Listing Date 2 July 2019
Fees
0.49% p.a.
Total expense ratio
0.04% Compare 1.38%
Compare ( Equity )
Dividend/ Taxes
Distribution policy Accumulating
Distribution frequency -
Fund domicile Ireland
Tax data Bundesanzeiger
Legal structure
Fund Structure Open-ended Investment Company (OEIC)
UCITS compliance Yes
Fund Provider Legal & General (LGIM)
Administrator BNY Mellon Fund Services (Ireland) Designated Activity Company
Investment Advisor Legal & General Investment Management Limited
Custodian Bank BNY Mellon Trust Company (Ireland) Limited
Revision Company EY
Fiscal Year End 30 June
Swiss representative State Street Bank International GmbH, München, Zweigniederlassung Zürich
Swiss paying agent State Street Bank International GmbH, München, Zweigniederlassung Zürich
Tax Status
Germany 30% tax rebate
Switzerland No ESTV Reporting
Austria Tax Reporting Fund
UK UK Reporting
Replication, swap, securities lending
Indextype Total return index
Swap counterparty -
Collateral manager BNY Mellon Fund Services (Ireland) Limited
Securities lending No
Securities lending counterparty
 
 
 

Performance of L&G Healthcare Breakthrough UCITS ETF USD Acc

Loading...
 
 

Exposure

Below you find information about the composition of the L&G Healthcare Breakthrough UCITS ETF USD Acc.

Top 10 Holdings
Weight of top 10 holdings
out of 87
16.56%
IRHYTHM TECHNOLOGIES ORD SHS
2.17%
DEXCOM ORD
1.76%
THERMO FISHER SCIENTIFIC ORD
1.72%
VOCERA COMMUNICATIONS ORD
1.69%
TELADOC HEALTH INC ORD
1.58%
INSULET ORD
1.56%
INTUITIVE SURGICAL ORD
1.55%
OMNICELL ORD
1.55%
CHRLS RIVER LABS ORD
1.50%
BROOKS AUTOMATION ORD
1.48%
Countries
United States
79.31%
Switzerland
3.75%
China
2.00%
United Kingdom
1.72%
Other
13.22%
Show more
Sectors
Health Care
92.42%
Technology
4.17%
Consumer Discretionary
1.01%
Other
2.40%
As of 29/10/2021
 
 

Description of L&G Healthcare Breakthrough UCITS ETF USD Acc

The L&G Healthcare Breakthrough UCITS ETF USD Acc invests in stocks with focus Health Care, World. The dividends in the fund are reinvested (accumulating).

The total expense ratio amounts to 0.49% p.a.. The fund replicates the performance of the underlying index by buying all the index constituents (full replication). The L&G Healthcare Breakthrough UCITS ETF USD Acc has 174m Euro assets under management. The ETF is older than 1 year and is domiciled in Ireland.
 

Look for similar ETFs

 

Performance chart of L&G Healthcare Breakthrough UCITS ETF USD Acc

Loading...
 

Chart comparison of all ETFs on this index (1)

Chart comparison of all ETFs on this category (12)

 

Returns of L&G Healthcare Breakthrough UCITS ETF USD Acc

Returns in years
Loading...
Returns in periods
Loading...
 
Monthly returns in a heat map
Loading...
 
 

Listings of L&G Healthcare Breakthrough UCITS ETF USD Acc

Loading...
 
Rolling 1 year volatility

Analyse the 1 year volatility over time.

Learn more
 

Take advantage of all comfort features and portfolio comparisons with justETF Premium. The Premium version includes features like simulation of ETF portfolios, details analysis, monitoring, rebalancing and more.

Upgrade now

Track your ETF strategies online

 
— Data provided by Trackinsight, etfinfo, Xignite Inc. and justETF GmbH.

All quotes are 15 minutes delayed stock exchange quotes or NAVs (=daily published by fund provider). Returns include dividend payments. There is no warranty for completeness, accuracy and correctness for the displayed information.